Emerging Microbiology Tests and Companies Developing New Technologies and Products

Date: February 10, 2012
Pages: 650
Price:
US$ 3,850.00 US$ 3,272.50
License [?]:
Publisher: Venture Planning Group
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C8D467A2103EN
Leaflet:

Download PDF Leaflet

Emerging Microbiology Tests and Companies Developing New Technologies and Products
This 650-page report provides a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for nearly 80 infectious diseases and viruses, including their scientific background, clinical significance and market needs for both current and emerging tests, vaccines, drugs and extensive listings of companies developing or marketing new technologies and products.

Contains 650 pages and 47 tables
1. AIDS

a. Background
    Structure and Composition
    Classification
    Origin of AIDS
    Animal Lentivirus Systems
    Virus Receptos
    HIV Infections in Humans
      Pathogenesis & Pathology: Overview of HIV Infection Course
    CD4T Lymphocytes and Memory Cells
    Monocytes and Macrophages
    Lymphoid Organs
    Neural Cells
    Viral Coinfections
      Clinical Findings
    Plasma Viral Load
    Pediatric AIDS
      Neurologic Disease
      Opportunistic Infections
      Cancer
    Immunity
      Virus Isolation
      Serology
      Detection of Viral Nucleic Acid and Antigens
    Infectivity
    Epidemiology
      Worldwide Spread of AIDS
      United States
      Routes of Transmission
b. Diagnostic Tests
    Laboratory Diagnosis
      Enzyme Immunoassay Interpretation
      Specific, Sensitivity, and Predictive Value of Enzyme Immunoassays
    Competition Assays
    Western Blot Technique
    Immuno-Fluorescence Assay (IFA)
    Radioimmunoprecipitation
    HIV-1/HIV-2 Combination Testing
    Methods of HIV-Antigen Detection
    Antigen Assays and Blood Screening
    Urine Tests
    Immunopathogenic Mechanism of HIV Infection
    DNA Probes
      Overview
      Quantitative Polymerase Chain Reaction
      In Situ PCR
      Needed Improvements
    Viral Load/Drug Resistance Testing
    Genotype and Phenotype Testing
    Blood Banking Consideration
c. Vaccines and Drugs
      Antiviral Drugs
      Vaccines Against HIV
    Transmission of HIV in Blood Products
    HIV Transmission in Transplant and Artificial Insemination Recipients

2. ADENOVIRUS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)

3. AEROMONAS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

4. ANTHRAX/BACILLUS ANTHRACIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

5. ARBOVIRUSES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

6. BABESIOSIS

a. Background

7. BACILLARY EPITHELIOID ANGIOMATOSIS (BEA) AND OTHER BARTONELLA (ROCHALIMAEA)

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

8. BLASTOCYSTIS HOMINIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

9. BRUCELLA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

10. CAMPYLOBACTER

a. Background
b. Diagnostic Tests
    Identification from Culture
c. Vaccines and Drugs

11. CANDIDA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

12. CHAGAS DISEASE

a. Background

13. CHANCROID

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

14. CHLAMYDIA

a. Background
    Chlamydia Psittaci
    Chlamydia Pneumoniae
    Chlamydia Trachomatis
b. Diagnostic Tests
c. Vaccines and Drugs

15. CLOSTRIDIUM DIFFICILE

a. Background
    Pediatric Infections
    Epidemiology
b. Diagnostic Tests
    Counterimmunoelectrophoresis
    Fluorescent-Antibody Assays
    Poloymerase Chain Reactions
c. Drugs and Vaccines

16. CORONAVIRUSES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

17. COXSACKIEVIRUSES

a. Background
    Herpangina
    Hand-foot-and-mouth syndrome
    Hepidemic Conjuctivitis
    Pharingitis
    Epidemic Pleurodynia
    Myodarditis,Pericarditis
    Overwhelming Infection of the Newborn
    Acute Aseptic Meningitis
    Undifferentiated Febrile Illness
    Fever with upper respiratory infection
    Encephalitis
    Asymptomatic Infection
b. Diagnostic Tests
c. Vaccines and Drugs

18. CREUTZFELDT-JAKOB’S DISEASE

a. Background
    Blood Transmission
b. Diagnostic Tests
    Major Commercial and Academic Players
      Bayer
      Disease Sciences/Bio Tec Global
      Imperial College of Medicine
      Ortho-Clinical Diagnostics
      Pall
      ProMetic Life Sciences
      Proteome Sciences/Idexx
      Q-One Biotech
      Serono
      U.S. Agricultural Research Service
c. Vaccines

19. CRYPTOSPORIDIUM PARVUM

a. Background
b. Diagnostic Tests
    Histologic
    Laboratory Parasitology
    Serodiagnosis
c. Vaccines and Drugs

20. CYCLOSPORA CAYETANENSIS

a. Background
    Asymptomatic Infection
    Diarrhea in Immunocompetent Persons
    Diarrhea in Immunocompromisedersons
b. Diagnostic Tests
c. Vaccines and Drugs

21. CYTOMEGALOVIRUS

a. Background
    Chorioretinitis
    Gastrointestinal
    Central Nervous System Disease
b. Diagnostic Tests
c. Vaccines and Drugs

22. EBOLA VIRUS

a. Background
    Epidemiology
    Hemorrhagic Fever
b. Diagnostic Tests
c. Vaccines and Drugs

23. E. COLI

a. Background
    Role of Escherichia Coli in Causing Diarrhea
    EPEC
    ETEC
    EIEC
    EHEC
b. Diagnostic Tests
c. Vaccines and Drugs

24. ECHOVIRUS

a. Background
    Acute Aseptic Miningitisis
    Encephalitis
    Exanthems
    Respiratory Disease
    Myope;ricarditis
    Neonatal Infections
b. Diagnostic Tests
c. Vaccines and Drugs

25. ENCEPHALITIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

26. ENTEROVIRUSES

a. Background
b. Diagnostic Tests
    Viral Isolation and Identification
    Antibody Tests
c. Vaccines and Drugs

27. EPSTEIN-BARR VIRUS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

28. GIARDIA LAMBLIA

a. Background
    Life Cycle and Morphology
    Morphology of Trophozoites
    Clinical Disease
b. Diagnostic Tests
c. Vaccines and Drugs

29. GONORRHEA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

30. GRANULOMA INGUINALE

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

31. HANTAVIRUS

a. Background
    Identification of the Agent
    Transmission
    Other Rodent Hantaviruses
    Distribution
    Hantavirus Diseases
    Epidemiology
    Addendum in Proof-Northeastern Connection
    Previously Unknown Pathogens
    Cases Nationwide
b. Diagnostic Tests
    An Immunohistochemistry Approach
    Hantavirus Rapid Diagnostic Test
    ELISA Diagnosis of Hantavirus Pulmonary Syndrome
    IgG ELISA
    IgM Capture ELISA
c. Vaccines and Drugs

32. HELICOBACTER PYLORI

a. Background
    Pathogenesis
    Role in Peptic Ulcer Disease
    Role in Gastric Cancer
    Nonulcer Dyspepsia
b. Diagnostic Tests
c. Vaccines and Drugs
    Specific Therapeutic Regimens
    Who Should Be Treated?
    Participants in Controlled Clinical Trials
    Patients with Refractory Peptic Ulcer
    Patients with Refractory NUD
    Patients in High-Risk Groups for Gastric Cancer

33. HEPATITIS

a. Background
b. Hepatitis A
c. Hepatitis B
d. Hepatitis C
    Classification
    Transmission of Infection
    Occupational Hazards
    Acute Hepatitis
    Diagnosis of Acute Infection
    Chronic Hepatitis
    HCV and Other Chronic Liver Diseases
    Alcoholic Liver Disease
    Hepatitis B Coinfection
    Cirrhosis and Hepatocellular Carcinoma
    Diagnostic Tests
    Possible Indications for HCV RNA Testing
    Conclusions and Future Direction
e. Hepatitis D
    Historical Perspective
    Epidemiology
    HBV-HDV "Coinfection" vs. "Superinfection"
    Methods of Detecting HDV
    Prevention
f. Hepatitis E
    Background
    Prevalence of the Disease
    Diagnostic Tests
    Epidemiologic Serosurveys
    Serologic Cross-Reactivity
g. Hepatitis G
    Vaccines and Drugs

34. HERPES SIMPLEX VIRUS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

35. HUMAN HERPES VIRUS-6 (HHV-6)

a. Background
    HIV-6 Infections
b. Diagnostic Tests
c. Vaccines and Drugs

36. INFLUENZA VIRUSES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

37. LEGIONELLA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

38. LYME DISEASE

a. Background
    Clinical Description
    Clinical Case Definition
    Laboratory Criteria for Diagnosis
    Case Classification
b. Diagnostic Tests
c. Vaccines and Drugs

39. LYMPHOGRANULOMA VENEREUM (LGV)

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

40. MALARIA

a. Background
b. Diagnostic Tests
    Potential Diagnositic Problems with Positive Patients from Non-endemic Areas
      Patient
      Laboratory
      Physician
c. Vaccines and Drugs

41. MEASLES (RUBEOLA)

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

42. MENINGITIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
    Development of Polysaccharide Vaccines
    Quadrivalent Vaccine Development
    Meningococcal A.C.Y. & W-135 Vaccines
    Efficacy of Group C Vaccine
    Efficacy of Group A Vaccine
    Combinations of Group A and C Vaccines
    Group B Efficacy Trials
    Future Direction

43. MICROSPORIDIUM

a. Background
    Prevalence and Geographic Distribution
    Sources of Human Infection and Transmission
b. Diagnostic Tests
    Light Microscopic Examination of Stool Specimens By Chromotrope Staining
    Stool Concentration Methods
    Chemofluorescent Agents
    Giemsa Staining of Stool Specimens
    Cytologic Diagnosis
    Histologic Examination
    Electron Microscopy
    Examination of Bodily Fluids
    Examination of Tissue Sections
    Immunofluorescence Detection Procedures
    Serology
    Cell Culture
    Approach to Diagnosis
    Evaluation of Patients with Presumptive Intestinal Microsporidiosis
    Evaluation of Patients with Presumptive Ocular Microsporidiosis
c. Vaccines and Drugs

44. MONONUCLEOSIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

45. MUMPS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
    Efficacy of Vaccination
    Future Issues

46. MYCOPLASMA

a. Background
    Ureaplasma Urealyticum & Mycoplasma Hominis
b. Diagnostic Tests
c. Vaccines and Drugs

47. PAPILLOMAVIRUSES

a. Background
    HPV in Cancer
    Cervical Neoplasm
b. Diagnostic Tests
c. Vaccines and Drugs
    Prevention

48. PARVOVIRUS B19

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

49. PNEUMONIA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

50. POLYOMAVIRUSES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

51. PSEUDOMONAS AERUGINOSA

a. Background
    Virulence Factors
b. Diagnostic Tests
c. Vaccines and Drugs

52. RABIES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

53. RESPIRATORY SYNCYTIAL VIRUS (RSV)

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

54. RHINOVIRUSES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

55. ROTAVIRUS (REOVIRUS)

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

56. RUBELLA(MEASLES)

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
    Developing Countries
    Elimination and Eradication of Measles
    New Developments

57. SALMONELLOSIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

58. SEPTICEMIA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

59. SHIGELLOSIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

60. STAPHYLOCOCCUS AUREUS

a. Background
    The Genus Taphylococcus
b. Diagnostic Tests
c. Vaccines and Drugs
    Prevention

61. STREPTOCOCCI

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
    Group A Streptococci
    Group B Streptococci

62. SYPHILIS

a. Background
b. Diagnostic Tests
    Biopsy
    Rabbit Infectivity Testing
    Other Diagnostic Modalities
c. Vaccines and Drugs
    Syphilis and HIV Infection
    Syphilis As a Cofactor for HIV Transmission
    Basic Science Issues

63. TOXOPLASMOSIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

64. TRICHOMONAS VAGINALIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

65. TUBERCULOSIS

a. Background
b. Diagnostic Tests
    Microscopic Characteristics
    Cultural Characteristics
    Detection of Antibodies
    Skin Tests
    MDRTB
c. Vaccines and Drugs

66. VIBRIO

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

67. WEST NILE VIRUS

a. Background
      Clinical Syndromes
b. Diagnostic Tests
c. Vaccines and Drugs

68. YERSINA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests

Ask Your Question

Emerging Microbiology Tests and Companies Developing New Technologies and Products
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: